Timely and accurate diagnosis through rapid tests can reduce the time to pathogen identification and facilitate faster, optimized antimicrobial treatment.

Diagnostics are an essential part of the global effort to avert the silent AMR pandemic through:

         1.   Allowing for active surveillance of drug resistance
         2.   Enabling the optimal use of existing drugs
         3.   Protecting and ensuring the appropriate use of new treatments

 On this page you will find links to key resources on Diagnostics for AMR. 

WHO report: Landscape of diagnostics against antibacterial resistance, gaps and priorities
In this report, the World Health Organization (WHO) has mapped available and pipeline diagnostics against AMR, identified gaps in the availability of such diagnostics in LMICs, and established a research and development (R&D) priority list of diagnostics against AMR for the next 3–5 years.

WHO: Molecular methods for antimicrobial resistance (AMR) diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
This manual provides information on types of molecular diagnostic tests and how to use them to monitor AMR and produce data for surveillance systems. 

Antimicrobial Susceptibility Testing: performance of in vitro antimicrobial susceptibility testing of bacteria and fungi
Guidance document for Antimicrobial Susceptibility Testing of bacteria and fungi. This brochure explains basic facts concerning the relevance and procedures of in vitro susceptibility testing. It provides information on the essential elements required to perform and utilize susceptibility testing as a tool for optimizing anti-infectious therapy.

AMR & Diagnostic Frontiers: developing and increasing access to AMR diagnostics in low-and-middle-income countries (LMICs)
This is a virtual event hosted by FIND and CARB-X discusses successful diagnostic developments from countries in the global south specifically India, Morrocco, and Senegal.

Access eLearning courses on Diagnostics